+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Contraceptives Market Analysis by Product (Topical, Oral Contraceptive Pills, Injectable Contraceptives), by Device (Male Condoms, Diaphragms, Female Condoms, Vaginal Rings, Sub Dermal Implants, Intra-Uterine Devices), and by Region - Forecast to 2029

  • PDF Icon

    Report

  • 145 Pages
  • May 2022
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5607063
The global contraceptives market size is estimated to be USD 23.52 billion in 2021 and is expected to witness a CAGR of 6.31% during the forecast period. NGO and government initiatives to encourage use of contraceptive methods is a key driver for the growth of the global contraceptives market. Additionally, rising need for checking unwanted pregnancy and increase in awareness about contraceptives worldwide are some of the other drivers propelling the market growth. Nevertheless, health risks related with the usage of various contraceptive methods and rapid growth in aging population and rise in cases of infertility are expected to restrain the global market growth.

By Product


Based on product, the market is segmented into topical contraceptives, oral contraceptive pills, and injectable contraceptives. In 2021, the oral contraceptive pills segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to widespread use of these products and effectiveness in avoiding unplanned pregnancy worldwide. Injectable contraceptives segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the increasing demand for these contraceptives as they last from 8 to 13 weeks.

By Device


Based on device, the market is segmented into contraceptive sponges, male condoms, diaphragms, female condoms, vaginal rings, sub dermal implants, and intra-uterine devices. In 2021, the intra-uterine devices segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to a rise in number of gynaecologists choosing these devices for contraception worldwide. Male condoms segment projected to grow at a profitable CAGR during the forecast period. This is attributed to a substantially huge consumer base, high usage and government programs generating awareness about them in the developing economies.

Regional Insights


In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the increase in occurrence of abortion, rise in population of women inside the age group of 15-44 years, growth in initiatives from government, accessibility of technological advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the increasing awareness among individuals, growing government initiatives relating to sex education for individuals are the major factors in this region. Competitor Insights Some of the key players in the contraceptives market are The Female Health Company (U.K.); Teva Pharmaceutical Industries Ltd. (Israel); Reckitt Benckiser Plc (U.K.); Pfizer, Inc. (U.S.); Mayer Laboratories, Inc. (U.S.); Cooper Surgical (U.S.); Church & Dwight Co. Inc. (U.S.); Actavis plc (U.S.); Merck & Co. (U.S.); and Ansell Limited (Australia). The leading players operating in the contraceptives industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The contraceptives market report is categorized into the following segments and subsegments:

Contraceptives Market, By Product (Revenue, USD Billion, 2021 - 2029)

  • Topical contraceptives
  • Oral contraceptive pills
  • Injectable contraceptives

Contraceptives Market, By Device (Revenue, USD Billion, 2021 - 2029)

  • Contraceptive sponges
  • Male condoms
  • Diaphragms
  • Female condoms
  • Vaginal rings
  • Subdermal implants

Intra-uterine devices

  • Copper Intra-uterine devices
  • Hormonal intra-uterine devices

Contraceptives Market, By Region (Revenue, USD Billion, 2021 - 2029)


North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
1.4.1. Research Models
1.4.1.1. Bottom-up Approach
1.4.1.2. Top-down Approach
1.4.1.3. Data Triangulation
1.4.2. Data Procurement
1.4.2.1. Internal Database
1.4.2.2. Secondary Research
1.4.2.3. Purchased Database
1.4.2.4. Primary Research
1.4.3. Data Analysis
1.4.3.1. Data Validation
1.4.3.2. Market Size Estimation
1.4.3.3. Market Forecast Model
1.4.4. Quality Assessment
2. Introduction: Contraceptives
3. Executive Summary
3.1. Global Market Scenario
3.2. Segment Market Scenario
3.3. Geographic Market Scenario
3.4. COVID-19 Impact
3.5. Competitive Landscape
4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.1.5. Driver 5
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.2.4. Restraint 4
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.3.4. Opportunity 4
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.4.4. Trend 4
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3
4.5.4. Challenge 4
5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. Value Chain Analysis
5.4. SWOT Analysis
5.5. Benchmark
6. COVID-19 Impact Analysis: Contraceptives Market
6.1. COVID-19: Overview
6.2. COVID-19 Impact on the Global Market
6.3. COVID-19 Impact on the Regional Markets
7. Market Analysis by Product
7.1. Topical contraceptives
7.1.1. Topical contraceptives Market Forecast, 2021-2029 (USD Million)
7.2. Oral contraceptive pills
7.2.1. Oral contraceptive pills Market Forecast, 2021-2029 (USD Million)
7.3. Injectable contraceptives
7.3.1. Injectable contraceptives Market Forecast, 2021-2029 (USD Million)
8. Market Analysis by Device
8.1. Contraceptive sponges
8.1.1. Contraceptive sponges Market Forecast, 2021-2029 (USD Million)
8.2. Male condoms
8.2.1. Male condoms Market Forecast, 2021-2029 (USD Million)
8.3. Diaphragms
8.3.1. Diaphragms Market Forecast, 2021-2029 (USD Million)
8.4. Female condoms
8.4.1. Female condoms Market Forecast, 2021-2029 (USD Million)
8.5. Vaginal rings
8.5.1. Vaginal rings Market Forecast, 2021-2029 (USD Million)
8.6. Subdermal implants
8.6.1. Subdermal implants Market Forecast, 2021-2029 (USD Million)
8.7. Intra-uterine devices
8.7.1. Intra-uterine devices Market Forecast, 2021-2029 (USD Million)
9. Regional Market Analysis
9.1. Regional Market Trends
9.2. Regional Market: Comparative Analysis
10. North America Contraceptives Market
10.1. North America Contraceptives Market
10.1.1. North America Market Size and Forecast, 2021-2029 (USD Million)
10.1.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
10.1.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
10.2. U.S. Contraceptives Market
10.2.1. U.S. Market Size and Forecast, 2021-2029 (USD Million)
10.2.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
10.2.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
10.3. Canada Contraceptives Market
10.3.1. Canada Market Size and Forecast, 2021-2029 (USD Million)
10.3.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
10.3.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
11. Europe Contraceptives Market
11.1. Europe Contraceptives Market
11.1.1. Europe Market Size and Forecast, 2021-2029 (USD Million)
11.1.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
11.1.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
11.2. Germany Contraceptives Market
11.2.1. Germany Market Size and Forecast, 2021-2029 (USD Million)
11.2.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
11.2.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
11.3. UK Contraceptives Market
11.3.1. UK Market Size and Forecast, 2021-2029 (USD Million)
11.3.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
11.3.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
11.4. France Contraceptives Market
11.4.1. France Market Size and Forecast, 2021-2029 (USD Million)
11.4.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
11.4.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
11.5. Spain Contraceptives Market
11.5.1. Spain Market Size and Forecast, 2021-2029 (USD Million)
11.5.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
11.5.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
11.6. Italy Contraceptives Market
11.6.1. Italy Market Size and Forecast, 2021-2029 (USD Million)
11.6.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
11.6.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
11.7. Rest of Europe Contraceptives Market
11.7.1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
11.7.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
11.7.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
12. Asia Pacific Contraceptives Market
12.1. Asia Pacific Contraceptives Market
12.1.1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
12.1.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.1.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
12.2. Japan Contraceptives Market
12.2.1. Japan Market Size and Forecast, 2021-2029 (USD Million)
12.2.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.2.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
12.3. China Contraceptives Market
12.3.1. China Market Size and Forecast, 2021-2029 (USD Million)
12.3.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.3.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
12.4. India Contraceptives Market
12.4.1. India Market Size and Forecast, 2021-2029 (USD Million)
12.4.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.4.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
12.5. South Korea Contraceptives Market
12.5.1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
12.5.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.5.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
12.5.1.3. Market Size and Forecast by Device, 2021-2029 (USD Million)
12.6. Australia Contraceptives Market
12.6.1. Australia Market Size and Forecast, 2021-2029 (USD Million)
12.6.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.6.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
12.7. Rest of Asia Pacific Contraceptives Market
12.7.1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
12.7.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.7.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
13. Latin America Contraceptives Market
13.1. Latin America Contraceptives Market
13.1.1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
13.1.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.1.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
13.2. Brazil Contraceptives Market
13.2.1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
13.2.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.2.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
13.3. Mexico Contraceptives Market
13.3.1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
13.3.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.3.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
13.4. Argentina Contraceptives Market
13.4.1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
13.4.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.4.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
13.5. Rest of Latin America Contraceptives Market
13.5.1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
13.5.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.5.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
14. MEA Contraceptives Market
14.1. MEA Contraceptives Market
14.1.1. MEA Market Size and Forecast, 2021-2029 (USD Million)
14.1.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
14.1.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
14.2. GCC Contraceptives Market
14.2.1. GCC Market Size and Forecast, 2021-2029 (USD Million)
14.2.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
14.2.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
14.3. South Africa Contraceptives Market
14.3.1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
14.3.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
14.3.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
14.4. Rest of MEA Contraceptives Market
14.4.1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
14.4.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
14.4.1.2. Market Size and Forecast by Device, 2021-2029 (USD Million)
15. Competitor Analysis
15.1. Market Share Analysis, 2021 & 2029
15.2. Competitive Mapping
15.3. Key Players Market Place Analysis
15.4. Major Recent Developments
16. Company Profiles
16.1. The Female Health Company (U.K.)
16.1.1. Company Snapshot
16.1.2. Company Overview
16.1.3. Financials
16.1.4. Product Benchmarking
16.1.5. Recent Developments
16.2. Teva Pharmaceutical Industries Ltd. (Israel)
16.2.1. Company Snapshot
16.2.2. Company Overview
16.2.3. Financials
16.2.4. Product Benchmarking
16.2.5. Recent Developments
16.3. Pfizer, Inc. (U.S.)
16.3.1. Company Snapshot
16.3.2. Company Overview
16.3.3. Financials
16.3.4. Product Benchmarking
16.3.5. Recent Developments
16.4. Mayer Laboratories, Inc. (U.S.)
16.4.1. Company Snapshot
16.4.2. Company Overview
16.4.3. Financials
16.4.4. Product Benchmarking
16.4.5. Recent Developments
16.5. Cooper Surgical (U.S.)
16.5.1. Company Snapshot
16.5.2. Company Overview
16.5.3. Financials
16.5.4. Product Benchmarking
16.5.5. Recent Developments
16.6. Church & Dwight Co. Inc. (U.S.)
16.6.1. Company Snapshot
16.6.2. Company Overview
16.6.3. Financials
16.6.4. Product Benchmarking
16.6.5. Recent Developments
16.7. Actavis plc (U.S.)
16.7.1. Company Snapshot
16.7.2. Company Overview
16.7.3. Financials
16.7.4. Product Benchmarking
16.7.5. Recent Developments
16.8. Merck & Co. (U.S.)
16.8.1. Company Snapshot
16.8.2. Company Overview
16.8.3. Financials
16.8.4. Product Benchmarking
16.8.5. Recent Developments
16.9. Ansell Limited (Australia)
16.9.1. Company Snapshot
16.9.2. Company Overview
16.9.3. Financials
16.9.4. Product Benchmarking
16.9.5. Recent Developments
16.10. Dilon Technologies, Inc. (US)
16.10.1. Company Snapshot
16.10.2. Company Overview
16.10.3. Financials
16.10.4. Product Benchmarking
16.10.5. Recent Developments
16.11. Planmed Oy (Finland)
16.11.1. Company Snapshot
16.11.2. Company Overview
16.11.3. Financials
16.11.4. Product Benchmarking
16.11.5. Recent Developments
16.12. Delphinus Medical Technologies, Inc. (US)
16.12.1. Company Snapshot
16.12.2. Company Overview
16.12.3. Financials
16.12.4. Product Benchmarking
16.12.5. Recent Developments
16.13. Company 13
16.13.1. Company Snapshot
16.13.2. Company Overview
16.13.3. Financials
16.13.4. Product Benchmarking
16.13.5. Recent Developments
16.14. Company 14
16.14.1. Company Snapshot
16.14.2. Company Overview
16.14.3. Financials
16.14.4. Product Benchmarking
16.14.5. Recent Developments
16.15. Company 15
16.15.1. Company Snapshot
16.15.2. Company Overview
16.15.3. Financials
16.15.4. Product Benchmarking
16.15.5. Recent Developments
16.16. Others Prominent Players
17. Conclusion & Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • The Female Health Company (U.K.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Reckitt Benckiser Plc (U.K.)
  • Pfizer Inc. (U.S.)
  • Mayer Laboratories Inc. (U.S.)
  • Cooper Surgical (U.S.)
  • Church & Dwight Co. Inc. (U.S.)
  • Actavis plc (U.S.)
  • Merck & Co. (U.S.)
  • Ansell Limited (Australia)